Published in Mov Disord on November 01, 2002
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol (2010) 2.20
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc (2008) 1.92
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat Rev Neurosci (2013) 1.82
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain (2011) 1.22
Parkinson's disease dementia: a neural networks perspective. Brain (2015) 1.10
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
The spectrum of cognitive impairment in Lewy body diseases. Mov Disord (2014) 0.96
Predictors of mild cognitive impairment in early-stage Parkinson's disease. Dement Geriatr Cogn Dis Extra (2013) 0.95
Rule-based category learning in patients with Parkinson's disease. Neuropsychologia (2009) 0.95
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. Eur J Nucl Med Mol Imaging (2012) 0.94
Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol (2012) 0.91
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology (2012) 0.90
Executive dysfunction in Parkinson's disease and timing deficits. Front Integr Neurosci (2013) 0.89
Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol (2014) 0.86
Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol (2004) 0.86
Beyond tremor and rigidity: non-motor features of Parkinson's disease. J Neural Transm (Vienna) (2009) 0.85
Neurodegeneration and microtubule dynamics: death by a thousand cuts. Front Cell Neurosci (2015) 0.82
Mild cognitive impairment in Parkinson's disease: the challenge and the promise. Neuropsychiatr Dis Treat (2005) 0.82
Conceptualization of depression in Parkinson's disease. Neuropsychiatr Dis Treat (2005) 0.82
Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson's disease. Front Behav Neurosci (2014) 0.82
Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease. Shanghai Arch Psychiatry (2013) 0.80
Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study. PLoS One (2014) 0.80
Mapping cortical atrophy in Parkinson's disease patients with dementia. J Parkinsons Dis (2013) 0.79
The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease. Mov Disord (2015) 0.79
Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease. Front Neurol (2015) 0.78
Screening for cognitive impairment in Parkinson's disease--which marker relates to disease severity? J Neural Transm (Vienna) (2006) 0.78
The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging. Mov Disord (2012) 0.78
Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease. Chin Med J (Engl) (2016) 0.78
Onset of Mild Cognitive Impairment in Parkinson Disease. Alzheimer Dis Assoc Disord (2016) 0.76
The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease. Front Neurol (2012) 0.76
The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease. Arch Clin Neuropsychol (2009) 0.76
Impairment of script comprehension in Lewy body spectrum disorders. Brain Lang (2013) 0.76
Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints. J Neurol (2012) 0.75
Evidence for age-associated cognitive decline from Internet game scores. Alzheimers Dement (Amst) (2015) 0.75
Sex Differences in the Clinical Progression of Parkinson's Disease. J Obstet Gynecol Neonatal Nurs (2016) 0.75
Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases. J Ophthalmol (2016) 0.75
The Development of the Dementia Screening Battery-100: Instrument Presentation, Reliability, and Construct Validity. Dement Geriatr Cogn Dis Extra (2017) 0.75
Differential Functional Connectivity Alterations of Two Subdivisions within the Right dlPFC in Parkinson's Disease. Front Hum Neurosci (2017) 0.75
Mild cognitive impairment in Parkinson's disease: a distinct clinical entity? Transl Neurodegener (2017) 0.75
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Food combination and Alzheimer disease risk: a protective diet. Arch Neurol (2010) 3.99
Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc (2002) 3.83
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
Hypertension and the risk of mild cognitive impairment. Arch Neurol (2007) 3.62
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron (2013) 2.94
Alcohol intake and risk of dementia. J Am Geriatr Soc (2004) 2.90
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87
Relation of diabetes to mild cognitive impairment. Arch Neurol (2007) 2.86
Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol (2006) 2.80
Risk of incident dementia in essential tremor: a population-based study. Mov Disord (2007) 2.73
Clinical update: diagnosis and treatment of essential tremor. Lancet (2007) 2.66
Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol (2004) 2.55
Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45
Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol (2011) 2.44
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Elderly-onset essential tremor is associated with dementia. Neurology (2006) 2.39
Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol (2005) 2.33
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27
Cognitive reserve and lifestyle. J Clin Exp Neuropsychol (2003) 2.27
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol (2003) 2.20
Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia (2006) 2.17
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09
Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke (2002) 2.08
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06
Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol (2006) 2.05
Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep (2004) 2.03
Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol (2008) 1.99
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Incidence of essential tremor in three elderly populations of central Spain. Neurology (2005) 1.94
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol (2008) 1.92
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
Age-related changes in brain activation during a delayed item recognition task. Neurobiol Aging (2006) 1.87
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
Purkinje cell loss is a characteristic of essential tremor: towards a more mature understanding of pathogenesis. Parkinsonism Relat Disord (2012) 1.86
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol (2008) 1.81
An event-related fMRI study of the neurobehavioral impact of sleep deprivation on performance of a delayed-match-to-sample task. Brain Res Cogn Brain Res (2004) 1.80
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Population-based case-control study of cognitive function in essential tremor. Neurology (2006) 1.77
Attitudes and practices among internists concerning genetic testing. J Genet Couns (2012) 1.75
Disparities in the recording of Parkinson's disease on death certificates. Mov Disord (2005) 1.75
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage (2008) 1.74
An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol (2006) 1.73
Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol (1985) (2005) 1.73
Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A (2010) 1.73
Axis is a feature of handwritten spirals in essential tremor. Mov Disord (2006) 1.70
Mortality from Parkinson's disease: a population-based prospective study (NEDICES). Mov Disord (2011) 1.70
Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? Neuroepidemiology (2011) 1.70
"Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor. J Neuropathol Exp Neurol (2010) 1.68
Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol (2004) 1.67
Stroke and memory performance in elderly persons without dementia. Arch Neurol (2006) 1.65
Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain (2013) 1.62
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol (2003) 1.59
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci (2013) 1.54